Sanders targets ‘unacceptable’ price of weight-loss drugs Ozempic and Wegovy

Vermont senator will grill CEO of Danish pharma giant whose drugs cost Americans 10 times more than abroad

The blockbuster weight-loss drugs Wegovy and Ozempic are arguably as omnipresent in the American zeitgeist as Taylor Swift or the iPhone. The drugs and others in its class are associated with the sparkle of Hollywood, on the lips of Oprah and considered transformative by doctors.

But the giant market for drugs like Wegovy, including not just the roughly 11% of adults who have diabetes but also the 42% of adults who have obesity, has conjured one of the demons of American healthcare - price.